Sagimet Biosciences (SGMT) Current Leases (2022 - 2026)
Sagimet Biosciences (SGMT) recorded quarterly Current Leases of $39000.0 in Q1 2026, down 50.0% quarter-over-quarter from $78000.0 in Q4 2025, and little changed on a YoY basis from $39000.0 in Q1 2025.
Sagimet Biosciences (SGMT) Current Leases (2022 - 2026) Analysis & Trends
Sagimet Biosciences' Current Leases history runs 5 years deep, the most recent figure standing at $39000.0 for Q1 2026.
- In Q1 2026, Current Leases changed 0.0% year-over-year to $39000.0; the TTM figure through Mar 2026 stood at $39000.0 (changed 0.0% YoY), while the FY2025 annual figure was $78000.0, changed 0.0% from the prior year.
- Current Leases was $39000.0 for Q1 2026 at Sagimet Biosciences, down from $78000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $153000.0 in Q2 2024 to a low of $26000.0 in Q1 2024.
- Historically, Current Leases has averaged $95153.8 across 5 years, with a median of $103000.0 in 2023.
- The sharpest annual moves came in 2023 and 2025: Current Leases slumped 51.13% in 2023, then jumped 50.0% in 2025.
- A 5-year view of Current Leases shows it stood at $133000.0 in 2022, then plunged by 51.13% to $65000.0 in 2023, then gained by 20.0% to $78000.0 in 2024, then changed by 0.0% to $78000.0 in 2025, then tumbled by 50.0% to $39000.0 in 2026.
- The last three Current Leases figures came in at $39000.0 (Q1 2026), $78000.0 (Q4 2025), and $115000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Sagimet Biosciences | 211.96 Mn | 211.96 Mn | - | 39,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39,000.00 |
| Dec 31, 2025 | 78,000.00 |
| Sep 30, 2025 | 115,000.00 |
| Jun 30, 2025 | 152,000.00 |
| Mar 31, 2025 | 39,000.00 |
| Dec 31, 2024 | 78,000.00 |
| Sep 30, 2024 | 116,000.00 |
| Jun 30, 2024 | 153,000.00 |
| Mar 31, 2024 | 26,000.00 |
| Dec 31, 2023 | 65,000.00 |
| Sep 30, 2023 | 103,000.00 |
| Jun 30, 2023 | 140,000.00 |
| Dec 31, 2022 | 133,000.00 |